Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$227K Hold
644
0.07% 106
2025
Q4
$211K Buy
+644
New +$204K 0.06% 106
2025
Q2
Sell
-644
Closed -$201K 109
2025
Q1
$201K Buy
+644
New +$190K 0.08% 92
2024
Q4
Sell
-644
Closed -$208K 97
2024
Q3
$208K Buy
+644
New +$211K 0.09% 76

Other funds holding AMGN

Atlas Wealth's AMGN Position: Q1 2026 in Review

Atlas Wealth held its Amgen (AMGN) position steady in Q1 2026 at 644 shares worth $227K. The position accounts for 0.07% of the portfolio, ranked #106.

Atlas Wealth first reported a position in AMGN in Q3 2024 and has held it in 4 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Atlas Wealth held 644 shares of Amgen worth $227K as of Q1 2026.
  • Atlas Wealth left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.07% of Atlas Wealth's portfolio in Q1 2026, its #106 holding.
  • Atlas Wealth first reported a position in Amgen in Q3 2024 and has held it in 4 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Atlas Wealth's 13F filing for Q1 2026, filed 6 May 2026.